Downregulation of MEIS1 impairs long-term expansion of CD34 + NPM1-mutated acute myeloid leukemia cells

Leukemia

Volumn 26, Issue 4, 2012, Pages 848-853

  Woolthuis, C M ^a   Han, L ^a,b   Verkaik Schakel, R N ^a   Van Gosliga, D ^a   Kluin, P M ^a   Vellenga, E ^a   Schuringa, J J ^a   Huls, G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; LIPOCORTIN 5; MUTANT PROTEIN; NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADHERENT CELL; APOPTOSIS; CD34 SELECTION; CELL EXPANSION; CELL FRACTIONATION; CELL ISOLATION; CELL POPULATION; ENZYME INDUCTION; EX VIVO STUDY; FAR WESTERN BLOTTING; GENE CLUSTER; GENE EXPRESSION; GENE MUTATION; HEMATOPOIETIC STEM CELL; HOMEOBOX; HOX GENE; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; LETTER; LEUKEMIA CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STROMA CELL; WILD TYPE;

ANTIGENS, CD34; DOWN-REGULATION; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS;

EID: 84859635323     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.277     Document Type: Letter

References (12)

1. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254-266. (Pubitemid 40110814)
2. Taussig DC, Vargaftig J, Miraki-Moud F, Griessinger E, Sharrock K, Luke T et al. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood 2010; 115: 1976-1984.
3. Martelli MP, Pettirossi V, Thiede C, Bonifacio E, Mezzasoma F, Cecchini D et al. CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. Blood 2010; 116: 3907-3922.
4. Alcalay M, Tiacci E, Bergomas R, Bigerna B, Venturini E, Minardi SP et al. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 2005; 106: 899-902. (Pubitemid 41076430)
5. Verhaak RG, Goudswaard CS, van Putten W, Bijl MA, Sanders MA, Hugens W et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood 2005; 106: 3747-3754. (Pubitemid 41739008)
6. Martelli MP, Manes N, Liso A, Pettirossi V, Verducci Galletti B, Bigerna B et al. A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. Leukemia 2008; 22: 2285-2288.
7. Falini B, Nicoletti I, Martelli MF, Mecucci C. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood 2007; 109: 874-885. (Pubitemid 46220630)
8. Schuringa JJ, Schepers H. Ex vivo assays to study self-renewal and long-term expansion of genetically modified primary human acute myeloid leukemia stem cells. Methods Mol Biol 2009; 538: 287-300.
9. van Gosliga D, Schepers H, Rizo A, van der Kolk D, Vellenga E, Schuringa JJ. Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells. Exp Hematol 2007; 35: 1538-1549. (Pubitemid 47419138)
10. de Jonge HJ, Woolthuis CM, Vos AZ, Mulder A, van den Berg E, Kluin PM et al. Gene expression profiling in the leukemic stem cell-enriched CD34(+) fraction identifies target genes that predict prognosis in normal karyotype AML. Leukemia 2011; e-pub ahead of print 15 July 2011; doi:10.1038/leu2011.172.
11. Majeti R, Becker MW, Tian Q, Lee TL, Yan X, Liu R et al. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc Natl Acad Sci U S A 2009; 106: 3396-3401.
12. Kumar AR, Li Q, Hudson WA, Chen W, Sam T, Yao Q et al. A role for MEIS1 in MLL-fusion gene leukemia. Blood 2009; 113: 1756-1758.